Purchase Order 75D30124P19061

Award Date 9/1/24
Potential Completion Date 8/31/26
Potential Value $243K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $245,000.00 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA to Emory University, a private research institution in Atlanta, GA. The contract is for a study titled "TAF-EVG INSERT STUDY" with a completion date of September 28, 2025. The contract does not have a set-aside designation. Emory University, through its Office of Sponsored Programs Division, is a major recipient of federal contracts and...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract, valued at $3,000.00, is for cancer and HIV research work to be completed by September 29, 2024. The contract is not set aside for any specific socioeconomic category. Emory University is a major recipient of federal research funding and has extensive capabilities across medical and scientific...
This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $144,702 firm-fixed-price purchase order to Emory University Office of Sponsored Programs for "LONG ARV" services. The order was placed on September 13, 2017, with a completion date of April 30, 2020. No set-aside designation was used. Emory University is a private university and non-profit organization that conducts public health research and programs for federal agencies, including...
This is a federal purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution located in Atlanta, Georgia. The contract, valued at $149,995.00, is for a PREP (Pandemic and All-Hazards Preparedness) study with a period of performance from September 23, 2016 to February 28, 2018. The contract is a firm fixed-price type and does not have a set-aside designation. Emory University, through its Office of Sponsored Programs...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,000.00 firm fixed-price purchase order to Emory University's Office of Sponsored Programs Division for biologicals. The work will be performed in Atlanta, Georgia and have a completion date of June 30, 2023. The contract is not set aside for a designated socioeconomic group. Emory University is a private research university that has a history of providing clinical trial, data...
This is a $107,120.64 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for a study on obesity and immunity, with a performance period that runs through August 13, 2024. Emory University, through its Office of Sponsored Programs division, is a major recipient of federal research contracts and grants, with a focus on biomedical research, public health, and...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract is for $149,824.00 and is for LAB TESTING services. It has an ultimate completion date of April 30, 2017. Emory University is the prime contractor, and there is no set-aside designation for this award. As a leading academic and research center, Emory University has an extensive track record of...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for $125,123.27 in firm fixed-price laboratory analysis services. It has a completion date of September 15, 2023. Emory University is the prime contractor on this contract, which is not set aside for any specific socioeconomic category. Emory is a major recipient of federal research contracts and grants,...

This is a $243,120 firm fixed-price purchase order contract awarded to Emory University by the Centers for Disease Control and Prevention (CDC) for the EMORY - ANTIRETROVIRAL SPECIMEN STUDY. The contract has an ultimate completion date of August 31, 2026 and is not set aside. Emory University, a private research institution in Atlanta, Georgia, is conducting this biomedical research study through its Office of Sponsored Programs division. The contract work involves developing, refining, and employing various animal models for studying infectious diseases, including those with pandemic potential and drug-resistant pathogens. This contract is likely related to the university's extensive federal grant and contract portfolio, which includes substantial funding from agencies such as the National Institutes of Health for infectious disease research.

Generated 11/19/24, 9:14 AM